Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
FX is stocked at 27 licensed dispensaries across New York, with the deepest coverage in New York, Queens, Staten Island, Syracuse, and Brooklyn. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In October 2026, FX concentrated 70.82% of sales in Vapor Pens with a 53.07% year-over-year lift and a 5.19% month-over-month gain, while Flower held 16.61% share on a 232.80% year-over-year surge but fell 29.63% month-over-month. Edible accounted for 10.47% share with 38.35% year-over-year growth and 7.47% month-over-month expansion, as Pre-Roll slipped to 2.10% share on a 73.50% year-over-year decline and a 71.68% month-over-month drop. With brand-wide sales up 49.82% year over year and average price up 7.90%, the mix implies FX is leaning into higher-price Vapor Pens (average $71.84) while trimming exposure to rapidly contracting Pre-Roll, indicating a portfolio shift that prioritizes margin-rich inhalables over low-ticket formats.
The mix trajectory points to FX defending a Vapor Pens-led identity while selectively scaling Flower: Vapor Pens’ 5.19% month-over-month advance alongside a 45th rank in New York Vapor Pens contrasts with Flower’s 29.63% month-over-month pullback despite a 232.80% year-over-year jump, suggesting trial-heavy gains retrenching to a sustainable base. Edible’s 7.47% month-over-month rise paired with 38.35% year-over-year growth, against Pre-Roll’s 71.68% month-over-month and 73.50% year-over-year declines, implies FX’s positioning is coalescing around premium Vapor Pens supported by steady Edible expansion, using Flower as a secondary growth lever rather than a core volume pillar.
Competitive Landscape
FX ranks #45 in New York Vapor Pens in October 2026, improving 1 position year over year from #46, yet slipping 3 spots since July 2026 from #42, which contrasts with Fernway climbing from #3 to #1 and Jetty Extracts jumping from #17 to #5. While FX’s best historical mark was #36 in June 2025, a 9-place gap from today indicates erosion relative to leaders, especially as Mfny (Marijuana Farms New York) moved up from #5 to #3 alongside a 55.41% year-over-year sales increase. The pattern implies FX is holding its year-over-year position but losing short-term share of voice as upward mobility concentrates among brands with double-digit rank gains, suggesting that without a catalyst FX’s trajectory points to further mid-pack compression.
Notable Products
FX’s October 2026 lineup is highly concentrated, with the top 10 items contributing 97.8% of sales and Lift Off - Hawaiian Haze Live Resin Disposable (2g) alone at 31.6%. All-in-one Disposables account for 65.6% of brand sales, so most of its revenue comes from a few vape SKUs.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.






